Cargando…

A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation

Glycine is an inhibitory neurotransmitter in the brainstem and spinal cord. Glycine transporter 2 (GLYT2) is responsible for the uptake of extracellular glycine. GLYT2 is specifically expressed in glycinergic neurons and thus has been used as a marker of glycinergic neurons. Here, we generated GLYT2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakizaki, Toshikazu, Sakagami, Hiroyuki, Sakimura, Kenji, Yanagawa, Yuchio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084908/
https://www.ncbi.nlm.nih.gov/pubmed/30135938
http://dx.doi.org/10.1016/j.ibror.2017.07.002
_version_ 1783346246474268672
author Kakizaki, Toshikazu
Sakagami, Hiroyuki
Sakimura, Kenji
Yanagawa, Yuchio
author_facet Kakizaki, Toshikazu
Sakagami, Hiroyuki
Sakimura, Kenji
Yanagawa, Yuchio
author_sort Kakizaki, Toshikazu
collection PubMed
description Glycine is an inhibitory neurotransmitter in the brainstem and spinal cord. Glycine transporter 2 (GLYT2) is responsible for the uptake of extracellular glycine. GLYT2 is specifically expressed in glycinergic neurons and thus has been used as a marker of glycinergic neurons. Here, we generated GLYT2 promotor-driven Cre recombinase (Cre)-expressing mice (GLYT2-Cre knock-in mice) to develop a tool for manipulating gene expression in glycinergic neurons. Cre activity was examined by crossing the GLYT2-Cre knock-in mice with a Cre reporter mouse line, R26R, which express β-galactosidase (β-gal) in a Cre-dependent manner. X-gal staining of GLYT2-Cre/R26R double transgenic mouse brains and spinal cords revealed that the Cre activity was primarily distributed in the brainstem, cerebellum, and spinal cord. These areas are rich in glycinergic neurons. Furthermore, we performed immunohistochemistry for β-gal combined with in situ hybridization for GLYT2 in the GLYT2-Cre/R26R double transgenic mouse brains to determine whether Cre activity is specifically localized to glycinergic neurons. The β-gal protein and GLYT2 mRNAs were colocalized in the cerebellar Golgi cells, dorsal cochlear nucleus, gigantocellular reticular nucleus, spinal trigeminal nucleus, nucleus of the trapezoid body, and lateral lemniscus. More than 98% of the GLYT2 mRNA-expressing cells in these brain regions also expressed β-gal, whereas 90–98% of the β-gal-positive cells expressed the GLYT2 mRNAs. Thus, Cre activity is specifically localized to glycinergic neurons with high fidelity in the GLYT2-Cre knock-in mice. The GLYT2-Cre knock-in mouse line will be a useful tool for studying glycinergic neurons and neurotransmission.
format Online
Article
Text
id pubmed-6084908
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60849082018-08-22 A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation Kakizaki, Toshikazu Sakagami, Hiroyuki Sakimura, Kenji Yanagawa, Yuchio IBRO Rep Article Glycine is an inhibitory neurotransmitter in the brainstem and spinal cord. Glycine transporter 2 (GLYT2) is responsible for the uptake of extracellular glycine. GLYT2 is specifically expressed in glycinergic neurons and thus has been used as a marker of glycinergic neurons. Here, we generated GLYT2 promotor-driven Cre recombinase (Cre)-expressing mice (GLYT2-Cre knock-in mice) to develop a tool for manipulating gene expression in glycinergic neurons. Cre activity was examined by crossing the GLYT2-Cre knock-in mice with a Cre reporter mouse line, R26R, which express β-galactosidase (β-gal) in a Cre-dependent manner. X-gal staining of GLYT2-Cre/R26R double transgenic mouse brains and spinal cords revealed that the Cre activity was primarily distributed in the brainstem, cerebellum, and spinal cord. These areas are rich in glycinergic neurons. Furthermore, we performed immunohistochemistry for β-gal combined with in situ hybridization for GLYT2 in the GLYT2-Cre/R26R double transgenic mouse brains to determine whether Cre activity is specifically localized to glycinergic neurons. The β-gal protein and GLYT2 mRNAs were colocalized in the cerebellar Golgi cells, dorsal cochlear nucleus, gigantocellular reticular nucleus, spinal trigeminal nucleus, nucleus of the trapezoid body, and lateral lemniscus. More than 98% of the GLYT2 mRNA-expressing cells in these brain regions also expressed β-gal, whereas 90–98% of the β-gal-positive cells expressed the GLYT2 mRNAs. Thus, Cre activity is specifically localized to glycinergic neurons with high fidelity in the GLYT2-Cre knock-in mice. The GLYT2-Cre knock-in mouse line will be a useful tool for studying glycinergic neurons and neurotransmission. Elsevier 2017-08-08 /pmc/articles/PMC6084908/ /pubmed/30135938 http://dx.doi.org/10.1016/j.ibror.2017.07.002 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Kakizaki, Toshikazu
Sakagami, Hiroyuki
Sakimura, Kenji
Yanagawa, Yuchio
A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation
title A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation
title_full A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation
title_fullStr A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation
title_full_unstemmed A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation
title_short A glycine transporter 2-Cre knock-in mouse line for glycinergic neuron-specific gene manipulation
title_sort glycine transporter 2-cre knock-in mouse line for glycinergic neuron-specific gene manipulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084908/
https://www.ncbi.nlm.nih.gov/pubmed/30135938
http://dx.doi.org/10.1016/j.ibror.2017.07.002
work_keys_str_mv AT kakizakitoshikazu aglycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT sakagamihiroyuki aglycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT sakimurakenji aglycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT yanagawayuchio aglycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT kakizakitoshikazu glycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT sakagamihiroyuki glycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT sakimurakenji glycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation
AT yanagawayuchio glycinetransporter2creknockinmouselineforglycinergicneuronspecificgenemanipulation